Form 4 holding
Director
Vyant Bio, Inc.
- Security class
- Common Stock, $0.0001 par value
- Shares / value
- 128,786
- Estimated value
- $171,801
- Report date
- 18 Apr 2022
- Price
- $1.33
- Ownership
- By Trust
Marcus Boehm
Insider Reports History
- Reporting-owner location
- Rutherford, NJ
- Latest reporting-owner signature
-
/s/ Andrew LaFrence, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Marcus Boehm
Form 4 holding
Director
Vyant Bio, Inc.
- Security class
- Common Stock, $0.0001 par value
- Shares / value
- 56,484
- Estimated value
- $75,350
- Report date
- 18 Apr 2022
- Price
- $1.33
- Ownership
- Direct
Insider Reports Filed by Marcus Boehm
4
Vyant Bio, Inc.
- Report period
- 18 Apr 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 19 Apr 2022, 19:35
- Role
- Director
- Next action
- Open filing details
4
Vyant Bio, Inc.
- Report period
- 30 Mar 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 01 Apr 2022, 16:30
- Role
- Director
- Next action
- Open filing details
4
Vyant Bio, Inc.
- Report period
- 18 Jan 2022
- Transactions
- 1
- Transaction value
- +$7,500
- Accepted by SEC
- 20 Jan 2022, 20:20
- Role
- Director
- Next action
- Open filing details
4
Vyant Bio, Inc.
- Report period
- 06 Dec 2021
- Transactions
- 1
- Transaction value
- +$8,450
- Accepted by SEC
- 07 Dec 2021, 08:00
- Role
- Director
- Next action
- Open filing details
4
Vyant Bio, Inc.
- Report period
- 27 Oct 2021
- Transactions
- 1
- Transaction value
- +$10,500
- Accepted by SEC
- 28 Oct 2021, 16:30
- Role
- Director
- Next action
- Open filing details
4
Vyant Bio, Inc.
- Report period
- 29 Sep 2021
- Transactions
- 1
- Transaction value
- +$12,200
- Accepted by SEC
- 30 Sep 2021, 08:45
- Role
- Director
- Next action
- Open filing details
4
Vyant Bio, Inc.
- Report period
- 25 Aug 2021
- Transactions
- 1
- Transaction value
- +$12,878
- Accepted by SEC
- 26 Aug 2021, 08:45
- Role
- Director
- Next action
- Open filing details
4
Vyant Bio, Inc.
- Report period
- 28 Jul 2021
- Transactions
- 1
- Transaction value
- +$14,624
- Accepted by SEC
- 28 Jul 2021, 21:45
- Role
- Director
- Next action
- Open filing details
4
Vyant Bio, Inc.
- Report period
- 30 Jun 2021
- Transactions
- 4
- Transaction value
- +$18,824
- Accepted by SEC
- 01 Jul 2021, 17:19
- Role
- Director
- Next action
- Open filing details
4
Vyant Bio, Inc.
- Report period
- 28 May 2021
- Transactions
- 1
- Transaction value
- +$18,400
- Accepted by SEC
- 01 Jun 2021, 17:10
- Role
- Director
- Next action
- Open filing details
4/A
Vyant Bio, Inc.
- Report period
- 30 Mar 2021
- Transactions
- 7
- Transaction value
- +$37,224
- Accepted by SEC
- 01 Jul 2021, 21:56
- Role
- Director
- Next action
- Open filing details